Literature DB >> 23585682

IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic.

Lauren A Zenewicz1, Xiaochen Yin, Guoyang Wang, Eran Elinav, Liming Hao, Liping Zhao, Richard A Flavell.   

Abstract

IL-22 is a good candidate to play a critical role in regulating gut microbiota because it is an important inducer of antimicrobial peptides and mucins in the gut. However, whether IL-22 participates in immune homeostasis by way of modulating gut microbiota remains to be elucidated. In this study, we find, through 16S rRNA gene-pyrosequencing analysis, that healthy IL-22-deficient mice had altered colonic microbiota, notably with decreased abundance of some genera, including Lactobacillus, and increased levels of others. Mice harboring this altered microbiota exhibited more severe disease during experimentally induced colitis. Interestingly, this altered gut microbiota can be transmitted to cohoused wild-type animals along with the increased susceptibility to this colitis, indicating an important role for IL-22 in shaping the homeostatic balance between immunity and colonic microbiota for host health.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23585682      PMCID: PMC3646987          DOI: 10.4049/jimmunol.1300016

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts.

Authors:  Akira Andoh; Zhuobin Zhang; Osamu Inatomi; Sanae Fujino; Yasuyuki Deguchi; Yoshio Araki; Tomoyuki Tsujikawa; Katsuyuki Kitoh; Shokei Kim-Mitsuyama; Atsushi Takayanagi; Nobuyoshi Shimizu; Yoshihide Fujiyama
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

2.  Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz
Journal:  Science       Date:  2010-03-04       Impact factor: 47.728

3.  STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing.

Authors:  Geethanjali Pickert; Clemens Neufert; Moritz Leppkes; Yan Zheng; Nadine Wittkopf; Moritz Warntjen; Hans-Anton Lehr; Sebastian Hirth; Benno Weigmann; Stefan Wirtz; Wenjun Ouyang; Markus F Neurath; Christoph Becker
Journal:  J Exp Med       Date:  2009-06-29       Impact factor: 14.307

4.  Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine.

Authors:  Manuela Raffatellu; Michael D George; Yuko Akiyama; Michael J Hornsby; Sean-Paul Nuccio; Tatiane A Paixao; Brian P Butler; Hiutung Chu; Renato L Santos; Thorsten Berger; Tak W Mak; Renée M Tsolis; Charles L Bevins; Jay V Solnick; Satya Dandekar; Andreas J Bäumler
Journal:  Cell Host Microbe       Date:  2009-05-08       Impact factor: 21.023

5.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

6.  A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity.

Authors:  Marina Cella; Anja Fuchs; William Vermi; Fabio Facchetti; Karel Otero; Jochen K M Lennerz; Jason M Doherty; Jason C Mills; Marco Colonna
Journal:  Nature       Date:  2008-11-02       Impact factor: 49.962

7.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Authors:  Daniel N Frank; Allison L St Amand; Robert A Feldman; Edgar C Boedeker; Noam Harpaz; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

8.  RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells.

Authors:  Stephanie L Sanos; Viet L Bui; Arthur Mortha; Karin Oberle; Charlotte Heners; Caroline Johner; Andreas Diefenbach
Journal:  Nat Immunol       Date:  2008-11-23       Impact factor: 25.606

9.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.

Authors:  Yan Zheng; Patricia A Valdez; Dimitry M Danilenko; Yan Hu; Susan M Sa; Qian Gong; Alexander R Abbas; Zora Modrusan; Nico Ghilardi; Frederic J de Sauvage; Wenjun Ouyang
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

10.  A core gut microbiome in obese and lean twins.

Authors:  Peter J Turnbaugh; Micah Hamady; Tanya Yatsunenko; Brandi L Cantarel; Alexis Duncan; Ruth E Ley; Mitchell L Sogin; William J Jones; Bruce A Roe; Jason P Affourtit; Michael Egholm; Bernard Henrissat; Andrew C Heath; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

View more
  119 in total

Review 1.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

Review 2.  Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.

Authors:  D J Silberger; C L Zindl; C T Weaver
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

3.  Diet-induced alterations in gut microflora contribute to lethal pulmonary damage in TLR2/TLR4-deficient mice.

Authors:  Yewei Ji; Shengyi Sun; Julia K Goodrich; Hana Kim; Angela C Poole; Gerald E Duhamel; Ruth E Ley; Ling Qi
Journal:  Cell Rep       Date:  2014-06-19       Impact factor: 9.423

4.  Accounting for reciprocal host-microbiome interactions in experimental science.

Authors:  Thaddeus S Stappenbeck; Herbert W Virgin
Journal:  Nature       Date:  2016-06-09       Impact factor: 49.962

5.  Antibiotics promote inflammation through the translocation of native commensal colonic bacteria.

Authors:  Kathryn A Knoop; Keely G McDonald; Devesha H Kulkarni; Rodney D Newberry
Journal:  Gut       Date:  2015-06-04       Impact factor: 23.059

6.  [Interleukin-22 - friend or foe?].

Authors:  J Leipe
Journal:  Z Rheumatol       Date:  2015-02       Impact factor: 1.372

7.  Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes.

Authors:  Aimon K Alkanani; Naoko Hara; Peter A Gottlieb; Diana Ir; Charles E Robertson; Brandie D Wagner; Daniel N Frank; Danny Zipris
Journal:  Diabetes       Date:  2015-06-11       Impact factor: 9.461

Review 8.  Cytokines, IBD, and colitis-associated cancer.

Authors:  Ralph Francescone; Vivianty Hou; Sergei I Grivennikov
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

9.  Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation.

Authors:  Ciara Gimblet; Jacquelyn S Meisel; Michael A Loesche; Stephen D Cole; Joseph Horwinski; Fernanda O Novais; Ana M Misic; Charles W Bradley; Daniel P Beiting; Shelley C Rankin; Lucas P Carvalho; Edgar M Carvalho; Phillip Scott; Elizabeth A Grice
Journal:  Cell Host Microbe       Date:  2017-06-29       Impact factor: 21.023

10.  PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis.

Authors:  M R Spalinger; S Kasper; C Chassard; T Raselli; I Frey-Wagner; C Gottier; S Lang; K Atrott; S R Vavricka; F Mair; B Becher; C Lacroix; M Fried; G Rogler; M Scharl
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.